GLOBUS MEDICAL, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
GLOBUS MEDICAL, INC. (GMED) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $116.35 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $116.35M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $116.39M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $116.83M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $28.99M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $116.35M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $116.39M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $116.83M 10-K · filed 2026-02-24 |
| 2025-09-30 | $28.99M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $58.56M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $83.99M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $112.21M 10-K · filed 2025-02-20 |
| 2024-09-30 | $114.94M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $113.88M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $112.95M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $118.08M 10-K · filed 2024-02-21 |
| 2023-09-30 | $144.10M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $14.05M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $13.99M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $16.89M 10-K · filed 2023-02-21 |
| 2022-09-30 | $15.60M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $15.82M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $16.06M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $18.36M 10-K · filed 2022-02-17 |
| 2021-09-30 | $18.26M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $17.82M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $17.78M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $18.86M 10-K · filed 2021-02-17 |
| 2019-12-31 | $13.86B 10-K/A · filed 2020-03-02 |
| 2018-12-31 | $11.51M 10-K · filed 2019-02-21 |
| 2017-12-31 | $8.70M 10-K · filed 2018-02-22 |
| 2016-12-31 | $6.89M 10-K · filed 2017-03-16 |
| 2015-12-31 | $1.57M 10-K · filed 2016-02-29 |
| 2014-12-31 | $1.54M 10-K · filed 2015-02-26 |
| 2013-12-31 | $531.00K 10-K · filed 2014-03-14 |
| 2012-12-31 | $527.00K 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |